Skip to content
‹ Back to IndustriesHealthcare

Introducing NARCAN® Nasal Spray to Dental Emergency Medical Kits

As the opioid crisis continues to spread, HealthFirst recognizes the need for dental offices to be equipped to respond to opioid overdoses. Following the recommendation of its Medical Advisory Board, HealthFirst has added NARCAN Nasal Spray to all SM Series Basic Emergency Medical Kits. This easy-to-administer drug could save a life in your practice. Harsh Reality…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from HealthFirst on MarketScale.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

As the opioid crisis continues to spread, HealthFirst recognizes the need for dental offices to be equipped to respond to opioid overdoses. Following the recommendation of its Medical Advisory Board, HealthFirst has added NARCAN Nasal Spray to all SM Series Basic Emergency Medical Kits. This easy-to-administer drug could save a life in your practice.

Harsh Reality of the Opioid Epidemic

The United States Centers for Disease Control and Prevention estimates that opioid overdoses claim an average of 115 American lives each day. This class of drug, which includes painkillers, heroin, and fentanyl, has swept the nation and caused a genuine crisis.

With two million Americans addicted to pain relievers and another 591,000 struggling with heroin addiction in 2015, this epidemic has affected people across the country of all walks of life. There’s no single type of person who becomes an addict.

Why Put This Medicine in Emergency Kits?

HealthFirst has seen evidence of opioid overdoses in the dental office. Despite your best efforts to keep patients safe, you can’t control the behavior of patients or their families. As this crisis continues, dental professionals should be prepared to address overdoses with a form of naloxone, such as NARCAN.

What is NARCAN?

NARCAN Nasal Spray contains naloxone, which reverses and stops the effects of opioids. When a patient overdoses on opioids, you can quickly administer this drug to restore breathing and stop the overdosing process. In some cases, you may need to deliver subsequent doses.

While patients may experience uncomfortable withdrawal symptoms after receiving naloxone, there are no known life-threatening side effects of this drug. When weighed against the potentially fatal effects of an opioid overdose, it’s clear that naloxone is a smart option. NARCAN Nasal Spray provides an easy way to administer this life-saving medication.

HealthFirst is proud to offer dentists the basic SM Series emergency medical kit with the life-saving drug, NARCAN. Learn more about HealthFirst’s emergency kits.

Read more at healthfirst.com

HealthFirst

Part of this channel

HealthFirst

Practice-ready solutions for dental and medical offices nationwide.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

QinFlow's new pressure bag device skips scheduled calibration and preventive maintenance

QinFlow's new pressure bag device skips scheduled calibration and preventive maintenance

QinFlow's PressSure is a battery-powered device that holds standard pressure bags at one of three fixed preset pressures during blood or IV fluid infusions.

  • 01The claims so far are design claims and an award shortlist; the signal worth watching is whether QinFlow or early adopters publish in-service data on reinflation time saved.

Oct 1, 2026

BedConnect’s Lindsey Joseph on matching post-acute care to patient needs

BedConnect’s Lindsey Joseph on matching post-acute care to patient needs

On I Don’t Care, BedConnect founder Lindsey Joseph and Kevin Stevenson discuss the limits of broad post-acute referrals. Their proposal is to match clinical needs, payer coverage and available beds before presenting options. CMS guidance and AHRQ discharge resources provide independent context; they do not establish BedConnect’s clinical outcomes.

  • 01BedConnect proposes matching clinical needs, payer coverage and bed availability before presenting post-acute options; this is the company’s approach, not independently validated outcome evidence.
  • 02CMS discharge-planning guidance emphasizes patient goals, treatment preferences and relevant provider quality and resource-use data.
  • 03Readmission comparisons need a defined patient group, time window and source; the interview’s roughly one-quarter/fourteen-day estimate has not been independently verified.

Sep 29, 2026

Rock Health: $7.4B went into digital health in H1 2026, and 20 rounds took 45%

Rock Health: $7.4B went into digital health in H1 2026, and 20 rounds took 45%

Rock Health: U.S. digital health startups raised $7.4 billion across 244 deals in H1 2026, up from $6.4 billion on 245 deals in H1 2025. The rebound is concentrated. Nineteen companies raised 20 $100 million-plus rounds that captured 45% of capital.

  • 01In H1 2026, 19 companies raised 20 mega-deals of $100 million or more, representing 45% of all capital invested, according to Rock Health.
  • 02According to Rock Health, the firm stopped labeling startups as “AI-enabled,” saying the technology is now too widespread for the label to be meaningful.

Sep 24, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512